Introduction
The virulence of bacteria, their capacity to cause disease, is generally dependent on the expression of a variety of properties which create a complex series of interactions between the invading pathogen and a susceptible host. Different factors may be required at different stages of infection : initially, the bacteria will usually need to adhere to tissues in sufficient numbers to establish infection; then they will need to obtain nutrients and to multiply while at the same time evading the host defence mechanisms. In some instances, they may need to invade host cells for survival or further dissemination within the host (Finlay & Falkow, 1989) . The recognition that bacterial pathogenicity is multifactorial has been followed by the more recent finding that many pathogens regulate the expression of sets of virulence factors in a coordinated manner as a response to changes in their environment (J. F. Miller et al., 1989a) . These changes would be seen when the pathogen first enters the host from an outside environment, when it transfers to different sites within the host or as a response to changing conditions within the host as a result of inflammation or an increased immune response. Coordination is achieved by a regulatory locus whose expression is itself responsive to environmental signals and which then in turn alters the expression of virulence-associated genes. This review will focus on the expression of the virulence factors of Bordetella pertussis, a Gram-negative bacterium that causes the human respiratory disease whooping cough. The techniques of molecular genetics found early application with B. pertussis during attempts to define important virulence factors and to ascertain Abbreviations : ACT, adenylate cyclase toxin ; AGG, agglutinogen; FHA, filamentous haemagglutinin ; HLT, heat-labile toxin ; HLY, haemolysin; PTX, pertussis toxin; TCT, tracheal cytotoxin. their role in immunogenicity and disease as a necessary prelude to the design of a new acellular vaccine (Weiss & Falkow, 1983) . This groundwork has subsequently led to the development of this organism as a model system for the genetic analysis of virulence.
The virulence factors of B. pertussis
Although the events which occur during the normal course of infection are still far from clear, progress has been made in identifying several factors that may function as virulence determinants. These have been reviewed extensively (Weiss & Hewlett, 1986; Friedman, 1988 ; Wardlaw 8c Parton, 1989) and will be described here only briefly. It is not known precisely how B. pertussis adheres to the cells of the respiratory tract, but several factors have been identified as putative adhesins : sero-specific agglutinogens (AGGs) 2 and 3 which are fimbrial antigens and elicit formation of agglutinating antibodies; a 69 kDa outer-membrane protein, pertactin, which is a non-fimbrial agglutinogen ; and filamentous haemagglutinin (FHA), a high-M, rodlike surface protein. The latter two components contain arginine-glycine-aspartic acid (RGD) sequences similar to those found in eukaryotic proteins such as fibronectin and which are involved in binding to integrin receptors on mammalian cells. Pertussis toxin (PTX), which is considered a major virulence factor of B. pertussis, appears also to act as an adhesin. Once established, growth of the organism is undoubtedly facilitated by the production of several toxins which interfere with the clearance mechanisms of the respiratory epithelium, damage host cells to provide nutrients and suppress the immune response. In addition, B. pertussis produces hydroxamate siderophores to obtain essential iron and also has the capacity to internalize iron directly from transferrin. PTX has a wide range of activities and may be responsible for the paroxysmal cough characteristic of pertussis. It is a protective immunogen and together with FHA is included in current acellular vaccines (Parton, 1991 ; Rappuoli et al., 1991) . Adenylate cyclase toxin (ACT or cyclolysin) is a bifunctional protein with adenylate cyclase and haemolysin (HLY) activities. It is able to penetrate and intoxicate mammalian cells by elevation of internal cyclic AMP levels and is thought to act primarily as an anti-phagocytic factor. Heat-labile or dermonecrotic toxin (HLT) and tracheal cytotoxin (TCT) may contribute to the disease by inducing ciliary paralysis and localized necrosis and tissue damage. Finally, the ability of B. pertussis to invade and survive within various mammalian cells has recently been established and is considered in more detail below.
Antigenic variation in B. pertussis
The notable capacity of B. pertussis to alternate between virulent and avirulent forms by both phenotypic (antigenic modulation) and genotypic (phase variation) means has been reviewed elsewhere (Robinson et al., 1986; . Antigenic modulation is the term applied to a freely reversible, phenotypic change, first noted by Lacey (1960) , whereby all the cells in a population can alter the expression of virulence determinants in a coordinate manner in response to environmental changes. Growth with NaCl produces virulent organisms, expressing all the virulence factors mentioned above, whereas the presence of modulators such as MgSO, or nicotinic acid promotes simultaneous loss of these factors (except TCT), and the expression of other antigens instead. Phase variation is a genotypic change also characterized by simultaneous loss of expression of virulence factors. Avirulent phase variants arise in a population at a frequency of and in some instances this has been shown to be reversible, although at a lower frequency Stibitz et al., 1989) . These two processes form the main subjects of this review. The expression of AGGs 2 and 3 may be regulated by either of these processes but they can also be lost and regained independently of each other at frequencies of to lo-, in a process known as serotype variation (Stanbridge & Preston, 1974) . Recent data indicate that both phase and serotype variation may occur by a similar mechanism.
to

Identification of a virulence regulon
The concept of a central regulatory locus which dictates the expression of a number of virulence-associated genes in B. pertussis was first brought to light by the pioneering work of Weiss et al. (1983 . They examined the virulence properties of a series of Tn5 insertion mutants defective in the expression of putative virulence determinants. Thus, for example, mutants defective in either PTX or ACT production were essentially avirulent in an infant mouse model of infection. Aside from establishing the importance of certain individual virulence factors in pathogenicity, this work identified a pleiotropically negative avirulent phenotype, designated Vir-, where a single Tn5 insertion prevented the expression of multiple virulence factors, including PTX, ACT, FHA and HLT. Weiss et al. (1983) suggested that a trans-acting factor(s) was encoded by the locus inactivated by Tn5 insertion and that this factor acted as a positive effector for the expression of virulence-associated genes. Weiss & Falkow (1 984) proposed that modulating conditions influenced the expression of this locus (designated vir and since renamed bug, Bordetella virulence gene), which in turn altered the expression of the virulence determinants. Molecular cloning techniques have since confirmed that the bug locus can act in trans to restore virulence expression to both avirulent phase variants and strains carrying Tn.5-induced bug mutations Knapp & Mekalanos, 1988; Stibitz et al., 1988; McGillivray et al., 1989) .
It was soon realized that if environmental signals affect the expression of virulence factors in a coordinate manner, then this affords a means for identification of unknown genes controlled by modulating signals. Knapp & Mekalanos (1988) further reasoned that virulence factors would for the most part be expressed at the cell surface. They used TnSphoA, a reporter for loci which encode secreted proteins, to characterize mutations in genes whose promoters were subject to modulation. Two sets of genes were identified : vir-activated genes, vag, from which expression was maximal in the absence of modulators (in the same manner as the major virulence factors decribed above) and vir-repressed genes, vrg, from which expression was derepressed in the presence of modulators. Two of the vrg-phoA fusions were cloned and returned to B. pertussis on a low copy number vector (Knapp & Mekalanos, 1988; Beattie et al., 1990 ). In the wild-type background the loci were not expressed in the absence of modulators, but were fully derepressed in a strain lacking bug activity. This confirmed that their expression was subject to repression by bug products. Weiss et al. (1989) used TnSlac, which has a promoterless P-galactosidase gene, to identify mutations in genes subject to modulation. Although, as with the study of Knapp & Mekalanos (1988) , several mutations were identified in previously undefined loci, all the genes identified by Weiss et al. (1989) and are simply derepressed in the absence of bvg activity. This is in contrast to the vag loci, which have an absolute requirement for bug activity and so produce a more readily distinguishable phenotype under modulating conditions. Fig. 1 summarizes the role of the bvg locus in directing the expression of the vag and vrg loci.
The bug regulatory locus
The locus has two genes, bvgA and bvgS, which constitute an operon and encode proteins with predicted sizes of 23 kDa and 135 kDa respectively Scarlato et al., 1990; Stibitz & Yang, 1991 ; Fig. 2) . The predicted amino acid sequences of BvgA and BvgS have extensive homology to a family of regulatory proteins that transmit sensory signals using conserved sequences in a two-component sensor/regulator system (Ronson et al., 1987; . These systems generally consist of a sensory transmembrane protein which has kinase activity and a cytoplasmic DNA-binding protein that when phosphorylated can activate gene expression. Proteins in the sensor class usually have a conserved Cterminal region which interacts with the regulator protein and a variable N-terminal portion that senses stimulatory signals. The regulator proteins display a conserved N-terminal receiver domain and a variable Cterminal region that interacts with gene sequences. These homologies suggested a model Stibitz & Yang, 1991) whereby BvgS acts as a transmembrane protein with a periplasmic N-terminal receiver domain which senses external signals and transmits them to the second component, BvgA, via phosphorylation which allows BvgA to regulate specific loci. Available data fully substantiate this model, but suggest that a hierarchy of regulation exists with different requirements for the control of expression of various bugdependent loci. The bug locus is closely linked to three genes involved in FHA production (Stibitz etal., 1988; Fig. 2) . A cosmid clone containing bvg andfha loci expressed FHA in E. coli and this expression was sensitive to modulation (Stibitz et al., 1988) . A subclone containing only thefha loci did not express FHA and all other attempts to express virulence-associated loci from their own promoters in E. coli have been unsuccessful. This fact can be exploited to determine if the presence of the bug locus alone is sufficient to restore expression in the E. coli background. This was confirmed for thefha locus by the construction of a single copy IacZYA fusion to the promoter region offhaB (the structural gene for FHA) integrated into the E. coli chromosome. Such a construct was activated 400-fold by the bvg locus supplied in trans and activity was severely reduced by modulation (J. F. Miller et al., 19896) . In this instance, the bug locus was sufficient for sensory transduction and transcriptional activation in E. coli. This was not true, however, for similar ZacZYA fusions toptxA and cyaA, the promoterproximal genes of the operons for PTX and ACT production (Nicosia et al., 1986; Locht & Keith, 1986; Brownlie et al., 1988; Glaser et al., 1988) , or for phoA fusions to two vrg genes. In these instances, the presence of the bug locus in trans had no effect on the transcription of these genes (J. F. Miller et al., 19893; Beattie et al., 1990; Goyard & Ullmann, 1991) . These data indicated that the influence of bvg on these loci was indirect and that additonal factors were perhaps required for their transcription.
Other work with the fhaB : : ZacZYA fusion in the E. coli chromosome showed that BvgA alone could act as a transcriptional activator . Overproduction of this protein from a strong heterologous promoter activated thefhaB fusion 600-fold. There was no such activation of a similar chromosomal fusion to the ptxA promoter. The activation of the fhaB fusion was not subject to modulation, indicating that the BvgS protein was required for sensing environmental signals. The observation that overproduction of a regulatory protein creates constitutive activity in the absence of its cognate sensor protein has been noted in other systems (see Roy et al., 1989 for references), including that of ToxR in Vibrio cholerae. ToxR is a regulatory protein analogous to BvgA that is responsible for the coordinate expression of several virulence factors in V. cholerae (V. L. Miller et al., 1987) . When expressed from a strong constitutive promoter in E. coli, ToxR activates expression from the virulence loci, but if the native toxR promoter is retained then full activation requires another protein, ToxS, the product of a gene immediately downstream of toxR in an operon similar to the bvg operon (V. L. . There is evidence that low level activation of regulatory proteins can occur via sensor proteins from other similar two-component systems present in the E. coli cell. This process, termed cross-talk, has been shown to occur in vitro (Ninfa et al., 1988) , but is inefficient and requires larger amounts of regulatory protein to be effective.
Construction of an in-frame deletion in the chromosomal bvgA gene in B. pertussis prevented transcription from the fhaB and ptxA promoters . Thus, although BvgA cannot activate theptx promoter in E. coli, it is clearly required for activation of the ptx operon in B. pertussis. This suggests that a regulatory hierarchy exists in B. pertussis for the expression of vag and vrg genes. Roy et al. (1989) proposed that BvgA would activate transcription of the fha locus and, in addition, one or more genes whose products are required for the positive expression of other vag loci or the repression of vrg loci. A cascade effect such as this might mediate temporal expression of virulence determinants as a result of environmental change.
The genes for auxiliary regulatory factors should be identifiable by mutations that affect a subset of virulence determinants. This possibility is supported by the observations of Goldman et al. (1984) , who examined phase variants of B. pertussis which arose at a frequency of to lo-'. They screened over 100 variants for HLY, PTX and FHA production and four phenotypic classes were observed : Hly+ Ptx+ Fha+ (9 %), Hly-Ptx+Fha+ (17%), Hly-Ptx-Fha+ (8%) and Hly-Ptx-Fha-(65%). The latter group probably represented the full avirulent Vir-phenotype. The isolation of only four phenotypes from a possible eight indicated that the loss of virulence factors had occurred in a nonrandom way, with FHA production being the last to be lost in accordance with the hierarchy of expression outlined above. A search for a cosmid clone from a gene library of B. pertussis able to promote bug activation of ptxA : : lac2 YA transcription in E. coli proved unsuccessful (J. F. Miller et al., 1990). However, gel-retardation studies have recently identified a 23 kDa protein, found in bug+ but not bug-strains, that binds to the promoter regions of theptx and cya loci (Huh & Weiss, 1991) . This is a protein distinct from BvgA which has been shown not to bind to the ptx promoter (Roy & Falkow, 1991; Huh & Weiss, 1991) . It is likely that this protein represents an auxiliary factor required for the expression of the ptx and cya genes. A locus, toxT, has recently been described in V . cholerae whose product(s) activates the promoters of certain virulence-associated genes dependent on ToxR (DiRita et al., 1991). These promoters, unlike, for example, that of ctxAB, the cholera toxin operon, are not directly activated by ToxR, but rather the toxTlocus is activated by ToxR and then produces the auxiliary regulatory factor(s). This is obviously similar to the pattern of regulation emerging in B. pertussis.
Transcription of bug-locus-controlled genes
The bug andfha loci
The bvg locus itself is subject to positive autoregulation. A single copy lacZYA fusion to the bvg promoter region integrated into the E. coli chromosome was activated 10-fold by the bug locus in trans on a multicopy plasmid . Activity was reduced to a basal level under modulating conditions. Similar results were obtained with bvg gene fusions created by allelic exchange in the chromosome of B. pertussis which confirmed a previous report in which Northern blot analysis had shown that modulation eliminated transcription of bvg-regulated genes, such as the ptx and cya loci, and reduced transcription from the bvg locus itself .
The close proximity of the bvg andfha loci and their capacity to be transcribed in E. coli has allowed the regulatory sequences controlling these genes to be thoroughly investigated (Fig. 2) . In all, five promoters have been identified in the 432 bp intergenic region betweenfhaB and bvgA (J. F. Miller et al., 1990; Scarlato et al., 1990; Roy et al., 1990) . Primer extension analysis identified two transcriptional start sites 90 bp (Pl) and 141 bp (P2) upstream of the bvgA gene both in B. pertussis and from the cloned genes in E. coli . S1 nuclease protection studies in B. pertussis located a third start site 270 bp (P3) from the translational start codon of bvgA and a fourth promoter (P4) on the DNA strand complementary to the bvg coding strand, starting 20 bp from bugA and driving transcription of a 155 bp anti-sense RNA complementary to the untranslated regions of the three RNAs transcribed from promoters PI, P2 and P3 . Finally, a start site for transcription of thefhaB gene was located on the same DNA strand as P4, but beginning 70 bp from the start of thefhaB gene in both B. pertussis and E. coli (J. F. Miller et al., 1990; Scarlato et al., 1990) . The bug and fha loci are therefore regulated by divergent promoters which are subject to activation by the products of the bug locus.
Inactivation of either the bugA or the bugs gene, or the imposition of modulating conditions, shut off transcription from the bug PI, P3 and P4 promoters and thefhaB promoter both in B. pertussis and from the cloned genes in E. coli Scarlato et al., 1990) . This confirmed that these promoters were positively regulated by the products of the bug locus and that both a functional BvgA and a BvgS protein were required for their activation. Transcription from the bug P2 promoter was maintained under these conditions and this constitutive activity is assumed to direct the synthesis of a low level of BvgA and S proteins. Scarlato et al. (1990) raised antibody against the BvgA protein and showed by Western blotting that BvgA was located in the B. pertussis cytoplasm, in keeping with its role as a DNA-binding protein. A constitutive low level of the protein was produced in BvgS-defective cells or in the wild-type under modulating conditions, presumably produced via activity at the bug P2 promoter. In the absence of modulation, BvgA concentration increased %fold, yet was lost only slowly upon re-addition of a modulator. Gross 8z Rappuoli (1989) had reported the immediate cessation of transcription from the bugcontrolled ptxA promoter upon addition of the modulator MgSO,. Within 10 min of addition of the modulator no mRNA directed by this promoter was found by Northern blotting. This observation indicated that modulation changed the activity but not the amount of BvgA. Addition of a cross-linking reagent to cell lysates established the presence only in non-modulated cells of a 46 kDa protein which cross-reacted with anti-BvgA serum . These authors therefore suggested that the 46 kDa protein may have corresponded to a complex of BvgA with another protein or to a dimer of BvgA itself. As a working hypothesis, they proposed that under non-inducing conditions only bug P2 is active to produce a low level of the BvgAS proteins. BvgA is in the monomeric form, but after a signal received by BvgS from the periplasm, BvgA is activated (possibly by phosphorylation) and adopts the dimeric form. This form trans-activates bug P1, P3, P4 and the fhaB promoters which results in increased synthesis of BvgA in sufficient amounts to activate the other bugdependent genes in the regulon. The active form of BvgA depends on continued signal transmission by BvgS and if this ceases, BvgA is rapidly inactivated. At the present time, several features of this model remain to be elucidated. It is not clear how the active form of BvgA is inactivated in such a way as to bring about an almost immediate cessation of transcription of bug-regulated loci on modulation. In addition, it has to be established if BvgA requires an auxiliary factor to function at loci such asptx and cya or whether it is simply required to activate genes for synthesis of secondary effectors which function in place of BvgA. The cross-linked 46 kDa protein described by Scarlato et al. (1990) could be BvgA combined with the 23 kDa protein described by Huh & Weiss (1991) , which associated with the promoter region of the ptx locus. This possibility might suggest that only one auxiliary protein was required to co-activate several loci as only the one cross-linked polypeptide was found besides BvgA alone. Alternatively, one or more auxiliary proteins of a similar M , might associate with BvgA. The role of the putative anti-sense RNA produced from bug P4 has not been established. It might be expected to interfere with translation of the complementary mRNA by binding to the ribosomal-binding site, but the data of Scarlato et ale (1990) show that the anti-sense transcript starts at least 5 bp beyond the putative ribosomalbinding site located 8 to 15 nucleotides upstream of the translational start site of the bvgA gene. In this case it may not interfere with the initiation of translation of the bugA mRNA and the authors suggested that it may instead have a positive regulatory function favouring interaction of the mRNA with the ribosomes.
Stibitz 8z Yang (1991) raised antibody against PhoA fusions to both BvgA and BvgS. They confirmed that the amount of BvgA protein detectable in B. pertussis by immunoblotting decreased under modulating conditions, but interestingly, the amount of BvgS protein showed little reduction. This indicated that the synthesis of BvgS was not regulated in the same way as BvgA. The way in which that is achieved has yet to be elucidated, but the mechanism presumably maintains a constant level of the sensor protein for continual interaction with the environment.
As the bug andfha loci were transcribed in a similar way both in B. pertussis and in E. coli, deletion analysis was used to establish that a minimum of 85 bp of sequence upstream of the fhaB transcriptional start site was required for activation by the bug locus in E. coli (Roy 8z Falkow, 1991) . DNAase protection studies showed that BvgA protected regions between -101 and -78 and -71 to -67 of thefhaB promoter. Within the -96 to -83 region was a 14 bp inverted repeat and deletions which eliminated this repeat domain were no longer activated by bug in trans. Moreover, the oligo-J . G . Coote nucleotide sequence corresponding to the -99 to -80 region, when present on a multicopy plasmid, completely inhibited activation of thefhaB promoter by the bvg locus (J. F. Miller et al., 1990) . This effect was assumed to be due to sequence-specific titration of the BvgA protein. DNAase protection studies also showed that BvgA protected a 32 bp region just upstream of bug P2. This region contained the heptameric sequences TTTCCTA and TTTGGTA as direct repeats. The former sequence made up one half of the inverted repeat in the fhaB promoter; the other half was TTTCTTA. The bug promoter region containing the direct repeats was also able to reduce trans activation of thefhaB promoter by BvgAS, presumably again due to titration of BvgA (J. F. Miller et al., 1990) . A similar construct carrying theptxA promoter region had no effect in the titration assay. This is in keeping with the absence of the heptameric sequences in the ptx promoter and the lack of BvgA activation of this locus. Differences noted in the capacity of BvgAS to trans-activate lacZYA fusions to thefha and bvg loci, 300-fold and less than 10-fold respectively, were ascribed to a proposed higher affinity of BvgA for the inverted repeat of thefha promoter rather than the direct repeat present in the bug promoter (Roy & Falkow, 1991) . The heptameric sequences present in the bvg and fha promoter regions are similar to the TTTTGAT element tandemly repeated in the promoter region of the ctxAB operon of I/. cholerae where the ToxR regulatory protein has been shown to bind (V. L. Miller et al., 1987) .
Other bug-regulated loci Deletion analysis of the ptx promoter region showed that at least 170 bp upstream of the transcriptional start site was necessary for bvg-dependent activation in B. pertussis (Gross & Rappuoli 1988 , 1989 . Deletions between -170 and -120 bp progressively reduced activity in a bug-proficient background. This region contained two 21 bp direct repeats between bases -157 and -117 where it was proposed that products associated with BvgAS activity were bound to activate transcription. In keeping with this, the binding of the 23 kDa protein, identified by Huh & Weiss (1991) , to the ptx promoter was prevented by an oligonucleotide corresponding to either repeat region. Huh & Weiss (1991) identified two similar 21 bp tandemly repeated sequences between bases -157 and -114 in the cya promoter region. Again, oligonucleotides corresponding to either of these repeat sequences bound strongly to the 23 kDa protein, but not to BvgA.
The promoter regions of several other virulenceassociated genes have now been sequenced (Livey et al., 1987; Charles et al., 1989; Willems et al., 1990; Beattie et al., 1990) . The repeat sequences characterized in the promoter regions of thefha, bvg, ptx or cya operons have not been identified in these determinants, although with the j m -3 gene for AGG3 synthesis, transcription was shown to require functional bug activity (Willems et al., 1990; MacGregor et al., 1991) . Similarly, in a bugbackground, the gene encoding the 69kDa adhesin pertactin was not expressed (Charles et al., 1989) and two urg genes were fully derepressed (Beattie et al., 1990) . However, the 21 bp sequence present in theptx promoter recurs at nucleotide 60 within the first gene of the ptx operon encoding the S1 subunit . Two related inverted repeat sequences of 12 and 15 bp have been described in the first 60 bp of the coding region of the fhaB gene (Relman et al., 1989) . The significance, if any, of these repeat units within the coding regions of these genes remains to be examined. It is clear, however, that modulation of transcription of two vrg genes occurs downstream of the promoter region (Beattie et al., 1990) . The expression of vrg-6 and vrg-18 was repressed in the presence of an active bug locus. Progressive deletion of the promoter region in both cases caused a drop in transcription efficiency due to loss of the promoter, but modulation of transcription was nevertheless maintained even when only 24 bp of vrg-18 upstream of the translational start codon remained. A 21 bp region of dyad symmetry forming a 10 bp inverted repeat was identified in the N-terminal coding region of each vrg gene and linker insertion in this region, identified as a hydrophobic signal sequence, abolished repression by the bvg locus. It is possible to visualize how bvg regulation might occur within the translated regions of the vrg genes. An effector molecule might bind to the mRNA and prevent translation which, coupled to increased mRN A degradation, would result in loss of function.
A 29 bp region containing an 11 bp inverted repeat was found in thejm-2 promoter region between 167 and 140 bp upstream of the translational start codon (Livey et al., 1987) . Interestingly, primer extension analysis placed the transcriptional start site at -146 bp which overlaps this repeat region (Walker et al., 1991) , although the size of the Jim-3 mRNA detected by Northern blotting conflicted with this data and indicated a shorter distance between the transcriptional and translational start sites (Willems et al., 1990) . A similarly positioned inverted repeat was found in thejm-3 gene promoter region, but was not identified in a determinant designated j m -X which has close homology to the Jim-2 and Jim-3 genes, yet does not express an identifiable fimbrial protein (Pedroni et al., 1988) . It remains to be determined if transcriptional regulators interact with these repeat regions.
Taken together these data indicate that, although the virulence-associated determinants of B. pertussis constitute a regulon controlled by the bug locus, the mechanism regulating expression may vary with different determinants. This variation almost certainly involves promoterspecific factors in the case of the vag genes, but control of vrg gene expression may be at the level of mRNA stability.
A model for antigenic modulation and phase variation
The human respiratory tract is the only known habitat for B. pertussis and the nature of the signals that might influence the activity of the bvg regulon in vivo are unknown. Nor is it clear how these signals influence the properties of BvgS, the proposed sensory component of the system. A number of environmental conditions besides the presence of MgS04 and nicotinic acid, including other salts, fatty acids and growth at 25 "C create modulating conditions (Lacey, 1960; Brownlie et al., 1985) . With regard to salts it is clear that the sulphate anion is important as MgC12 has no modulating effect, but other cations such as Na+, K+ or NH,+ can replace Mg2+ (Brownlie et al., 1985; . Modulation can be induced by analogues of nicotinic acid where the pyridine ring is substituted with a carboxyl group, but not by nicotinamide (Wardlaw et al., 1976; Schneider & Parker, 1982) . Modification of the carboxyl group by methylation or acetylation abolishes the modulating activity of nicotinic acid. These studies suggest that sulphate ions and nicotinic acid induce modulation through specific intermolecular reactions, but the nature of these and their relevance to events in vivo is not known. It has been suggested that excess sulphate, an ion with a similar structure to that of phosphate, may interfere with the phosphorylation mechanism whereby BvgS transmits external signals to BvgA . In other systems, such as the toxRS regulon in I/. cholerae, osmolarity and temperature have been shown to play an important role in the expression of virulence determinants (V. L. Miller & Mekalanos, 1988; .
There is indirect evidence to indicate that BvgS may act as a dimer to activate BvgA. Stibitz & Yang (1990) created several in-frame mutations in the bugs gene by linker insertion and returned these constructs to B. pertussis on a multicopy plasmid. Four of five mutations were trans-dominant to the wild-type. One interpretation of this is that BvgS acts as a multimer and that excess mutant protein expressed from the plasmid created nonfunctional oligomers having at least one defective protein constituent. In keeping with this, in the reverse situation, when the wild-type protein was overproduced in the mutant strains, a wild-type phenotype resulted. Moreover, intracistronic complementation occurred between two mutations at either end of the bugs gene. The two mutant proteins were non-functional individually, but functional when expressed together in the same cell. Stibitz & Yang (1990) proposed that activation of BvgA (which itself may act as a dimer) is dependent on the dimeric state of BvgS which is sensitive to modulating conditions. A model for signal transmission can be envisaged (Fig. 3) which relies on dimerization of BvgS starting in the periplasm and which when completed serves to activate BvgA in the cytoplasm. BvgA in turn may be induced to take up an active dimeric form or more readily be able to associate with another effector molecule. In V. cholerae, dimerization of ToxR catalysed by ToxS has been proposed as a critical event for the subsequent activity of ToxR as a DNAbinding protein . Although the ToxR and S proteins appear not to have the transmitter/receiver relationship characteristic of other two-component systems, ToxR is nevertheless homologous at its N-terminal end to the DNA-binding domains of several regulator proteins . One unusual feature of BvgS is that it has at its C-terminal end (C, in Fig. 3 ) a region homologous to receiver domains normally present in regulatory molecules, including BvgA (Arico et aZ., 1989) . The protein thus has a 'receiver' module (C2, residues 947 to 1064) fused to the typical transmitter module (Cl, residues 698 to 930) normally associated with sensor proteins. The role of this extra 'receiver' module is at present unknown, but it is certainly required for bug regulation as a Tn5 insertion in this region, or an in-frame linker insertion a short distance downstream of the region, gave a Bvgphenotype . However, Lee et al. (1990) examined a B. pertussis derivative with a plasmid insertion in the bvgS gene which effectively removed 85 amino acids from the C-terminal end of the protein. This strain had an intermediate phenotype with regard to virulence factor expression; it was Hly-Ptx-, but produced small amounts of FHA and pertactin and was able to invade HeLa cells (see below). These features were not exhibited by the Bvg-strains mentioned above, nor by a Bvg-strain carrying a frame-shift mutation at residue 1075 in a repetitive cytosine sequence . This latter mutation resulted in the loss of an additional 49 residues from BvgS starting just beyond the C2 'receiver' module. The additional 'receiver' domain is thus important for bog activity, but the extreme Cterminal end of the protein may not be required for expression from promoters directly activated by BvgA, such as that for FHA, and possibly those for pertactin synthesis and cell invasion, but may have a role in the activation of other bug-dependent loci. Knapp & Mekalanos (1988) described a series of spontaneous mutants that expressed vag functions such as HLY, PTX and FHA under modulating conditions and which showed no derepression of vrg functions. The constitutive phenotype was apparent in the presence of either MgS04, nicotinic acid or low temperature, confirming that the different modulators affected gene expression by a common component associated with the constitutive mutation, designated mod. It might have been expected that mod either represented a mutation in the bug locus which locked BvgS or BvgA in the active form, making either unable to respond to modulating signals, or it identified another gene whose product interacted directly with modulating signals. The mutation was trans-dominant to the wild-type and was closely linked to the bug locus. Knapp & Mekalanos (1988) suggested that the mod gene may encode, by analogy with ToxS of V . cholerae, a protein which interacts with BvgS to modulate its activity. The additional 'receiver' domain on BvgS could be the site of such an interaction. A complicating factor for this interpretation is that in E. coli only the bug locus carried on a plasmid was apparently required to trans-activate the chromosomal fhaB::lacZYA fusion (J. F. Miller et al., 19893) . The 5.1 kb insert in the plasmid corresponded to the 5'-and 3'-boundaries of the bvgAS operon and further deletions at either end eliminated activity. In no case was a deletion that affected modulation, but not activation detected. This might suggest that BvgA and S function in E. coli without the mod gene product, but J. F. reported similar constitutive mutants which retained their activity in E. coli and trans-activated fhaB : : lac2 YA expression even under modulating conditions. The precise nature of these constitutive bugassociated mutations has thus still to be defined.
For one strain of B. pertussis that has been studied in detail, the genotypic change to the avirulent form (phase variation) has been shown to be a reversible process caused by insertion or deletion of a cytosine residue in a run of six such residues within the bvgS gene . In other instances, stable phase variants have been shown to possess small deletions or additions to the bug locus (McGillivray et al., 1989; . Expression of AGGs 2 and 3 is controlled by the bvg locus (Walker et al., 1990 : Willems et al., 1990 MacGregor et al., 1991) , but they can be lost and regained independently during serotype variation. This change is dependent on cis-acting elements associated with theJim genes rather than the production of transacting molecules (W illems et al., 1990 ; MacGregor et al., 199 1) . Willems et al. (1 990) produced evidence which suggested that serotype variation may be due to insertion/deletion events within a cytosine-rich region located some 70 bp upstream of the translational start site of the Jim genes. This region contained 15 and 13 cytosine residues respectively in the Jim-2 and Jim-3 genes sequenced from strains producing high levels of these AGGs, to between 12 and 9 residues from strains producing low levels and down to 7 residues for a gene Jim-X assumed not to produce a fimbrial protein. A variant of a serotype 2+,3-strain was selected by in vivo passage after infection of a rabbit. After 40 d, serotype 2+,3+ strains were isolated and the promoter region of one of these strains, when sequenced, had an extra cytosine inserted in the cytosine-rich region. The regions where these alterations occurred lies outside of the coding region of the Jim genes and Willems et al. (1990) suggested that the number of cytosine residues may influence the ability of the transcriptional apparatus to express thefim genes. Insertions or deletions in the run of cytosine residues may, for example, alter the alignment of regulatory factors with respect to the RNA polymerase. Reiterated base sequences are known to cause duplications or deletions during DNA replication, and antigenic variation by insertions or deletions has been documented for several pathogens (Stem & Meyer, 1987 ; Rosquist et aZ., 1988 ; Weiser et aZ., 1989) . However, in all these instances, and including that of BvgS in B. pertussis, translation is affected due to frame-shift alterations. The significance of the alterations outside of the coding regions of the f;m genes remains to be established.
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Antigenic modulation and phase variation in v i m
The role of the BvgAS sensory and regulatory system in pathogenesis is unknown. However, it is unlikely that such a system would exist if it was not important for the organism to adapt to a changing environment by altering the expression of important antigens. The human respiratory tract is the only known habitat for B. pertussis and no other reservoir or asymptomatic carrier state has been identified. Two early reports indicated that both phase variation and antigenic modulation occur in vivo and are not simply laboratory phenomena. Kasuga et al. (1954) isolated avirulent phase variants from pertussis patients only in the later stages of the disease. It is unknown at present if the reversible frame-shift mutations in the extended cytosine residues of BvgS ) represent a programmed genotypic change which is of use to the bacterium and has consequently been maintained against evolutionary elimination in what is a highly adapted organism. Lacey (1960) observed that, of sera from 50 convalescent patients, 42 possessed antibodies specific to the virulent phase and three to the avirulent phase. Only two of the sera with virulent phase antibodies were from adults whereas all three sera with avirulent phase antibodies were from patients over the age of nineteen. These latter patients had only a mild cough, but were culture positive for 2 to 5 months. Thus the avirulent phase may represent a pathogenically dormant state associated with the later stages of infection, when the host immune response has developed, and may be a strategy for immune evasion and persistence within the host. Lacey (1960) noted that avirulent phase antigens expressed in the presence of modulators were less immunogenic than those from the virulent phase and that these were the antigens characteristic of the long-term carriers of B. pertussis. The avirulent phase antigens described by Lacey (1960) may thus be the products of the vrg genes which may contribute to the persistence of the organism. This is of concern if new acellular vaccines are to consist of antigens produced only during the virulent phase. Robinson et al. (1986) suggested that, as modulated organisms adhere less readily to mammalian cells than those expressing virulent phase antigens, modulation may aid expulsion of bacteria and thus enhance transmission of the disease. As disease progresses local tissue damage may give rise to signals that favour modulation and, as temperatures below 28 "C induce modulation, this condition would be maintained outside the host. It is not known at present if B. pertussis can maintain an environmental reservoir outside the human host and it has not been shown experimentally that modulated cells are capable of switching to the virulent phase and initiating infection in animal models.
The colonization site of the bacterium is assumed to be the surface of the ciliated respiratory epithelium, but recent reports have shown that B. pertussis can be taken up by and survive within mammalian epithelial cells and macrophages (Ewanowich et al., 1989; Lee et al., 1990; Saukkonen et al., 199 1) . In non-professional phagocytes the process is mediated by microfilament-dependent endocytosis and requires products controlled by the bvg locus, but these have not been identified. In macrophages, modulated cells and cells deficient in BvgAS activity were as efficiently internalized as virulent organisms (Lee et al., 1990 ) by a host-specified mechanism (Saukkonen et al., 1991) . Uptake was followed by bacterial survival and slow multiplication over a 4 h period. Recent data have shown that bacteria taken up by leucocytes induced high levels of the respiratory burst normally associated with bacterial killing by phagocytes, but prevented phagosome-lysosome fusion, and this feature was suggested as the means of survival (Steed et al., 1991) . When rabbits were infected with B. pertussis, approximately half of the total bacterial population recovered from tracheal lavage fluid 24 h after infection appeared to reside within macrophages (Saukkonen ef al., 1991) . Pulmonary oedema was attributed to the extracellular cilia-associated bacterial population, however, which indicated either that the intracellular location of bacteria did not permit release of toxins or that the bacteria were induced to modulate to the avirulent phenotype. This latter possibility is supported by the observation that a mutant strain of B. pertussis constitutively expressing ACT, independently of bug activity, continued to produce enzymic activity after entry into alveolar macrophages in vitro whereas the parent strain showed a steady decline in activity over a 2 h period (Masure & Barrett, 1991) . Cessation of ACT production by the wild-type bacteria was interpreted to mean that antigenic modulation had occurred within the macrophages.
The significance of a possible intracellular population of B. pertussis in vivo is open to speculation. Bacteria would be protected from antibody and complement and, in a quiescent state, would represent an asymptomatic carrier condition. The factors that might influence their re-emergence from host cells have not been examined. The full implications of regulatory systems like bvgAS in B. pertussis and toxRS in V. cholerae have yet to be realized, but they both clearly offer a means of antigen switching as a response to environmental change. Moreover, there appears to be a hierarchy of expression of antigens, at least in the virulent phase. In the case of B. pertussis, BvgA serves to activate genes for its own production and for FHA and possibly also for pertactin and proteins for host cell invasion, together presumably with at least one other unidentified gene whose product J . G . Coote almost certainly acts as an effector for the expression of other virulence factors such as PTX and ACT. It is possible that this latter gene expression may be subject to different environmental signals relayed through the bvg locus. From the viewpoint of the bacterium, efficient attachment to respiratory tissue would be followed in a controlled sequence by production of factors that promote establishment of the organism and subsequent evasion of host defences. In the later stages of infection the organism may adopt the avirulent, immunogenically inert condition to allow survival or onward transmission to a new host.
